カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/11/22 | 1,209 | 1,209 | 1,192 | 1,200 | -3 | -0.2% | 1,200 |
| 2024/11/21 | 1,206 | 1,226 | 1,201 | 1,203 | -27 | -2.2% | 2,200 |
| 2024/11/20 | 1,231 | 1,237 | 1,230 | 1,230 | -1 | -0.1% | 1,800 |
| 2024/11/19 | 1,207 | 1,231 | 1,188 | 1,231 | +23 | +1.9% | 5,800 |
| 2024/11/18 | 1,177 | 1,212 | 1,177 | 1,208 | +13 | +1.1% | 3,000 |
| 2024/11/15 | 1,210 | 1,210 | 1,183 | 1,195 | -17 | -1.4% | 1,200 |
| 2024/11/14 | 1,214 | 1,214 | 1,181 | 1,212 | -1 | -0.1% | 2,600 |
| 2024/11/13 | 1,214 | 1,214 | 1,200 | 1,213 | -3 | -0.2% | 1,500 |
| 2024/11/12 | 1,214 | 1,219 | 1,199 | 1,216 | +2 | +0.2% | 3,300 |
| 2024/11/11 | 1,174 | 1,220 | 1,174 | 1,214 | +40 | +3.4% | 5,900 |
| 2024/11/08 | 1,191 | 1,192 | 1,174 | 1,174 | -16 | -1.3% | 900 |
| 2024/11/07 | 1,161 | 1,190 | 1,161 | 1,190 | -1 | -0.1% | 1,500 |
| 2024/11/06 | 1,186 | 1,196 | 1,161 | 1,191 | +21 | +1.8% | 2,100 |
| 2024/11/05 | 1,160 | 1,178 | 1,160 | 1,170 | ±0 | ±0% | 800 |
| 2024/11/01 | 1,156 | 1,196 | 1,155 | 1,170 | +2 | +0.2% | 6,900 |
| 2024/10/31 | 1,171 | 1,173 | 1,151 | 1,168 | -3 | -0.3% | 2,700 |
| 2024/10/30 | 1,181 | 1,181 | 1,150 | 1,171 | -1 | -0.1% | 11,700 |
| 2024/10/29 | 1,178 | 1,191 | 1,171 | 1,172 | -3 | -0.3% | 800 |
| 2024/10/28 | 1,175 | 1,194 | 1,174 | 1,175 | -13 | -1.1% | 3,500 |
| 2024/10/25 | 1,214 | 1,215 | 1,173 | 1,188 | -20 | -1.7% | 20,300 |
| 2024/10/24 | 1,200 | 1,208 | 1,186 | 1,208 | +5 | +0.4% | 3,700 |
| 2024/10/23 | 1,209 | 1,211 | 1,191 | 1,203 | -6 | -0.5% | 1,000 |
| 2024/10/22 | 1,208 | 1,210 | 1,200 | 1,209 | +1 | +0.1% | 2,000 |
| 2024/10/21 | 1,189 | 1,208 | 1,189 | 1,208 | +19 | +1.6% | 1,500 |
| 2024/10/18 | 1,190 | 1,194 | 1,183 | 1,189 | -1 | -0.1% | 1,800 |
| 2024/10/17 | 1,188 | 1,193 | 1,188 | 1,190 | -4 | -0.3% | 2,100 |
| 2024/10/16 | 1,188 | 1,206 | 1,188 | 1,194 | -24 | -2% | 4,000 |
| 2024/10/15 | 1,225 | 1,225 | 1,204 | 1,218 | -7 | -0.6% | 1,200 |
| 2024/10/11 | 1,205 | 1,225 | 1,200 | 1,225 | +17 | +1.4% | 3,700 |
| 2024/10/10 | 1,208 | 1,214 | 1,205 | 1,208 | ±0 | ±0% | 2,600 |
| 2024/10/09 | 1,173 | 1,230 | 1,173 | 1,208 | +37 | +3.2% | 9,100 |
| 2024/10/08 | 1,175 | 1,180 | 1,165 | 1,171 | -4 | -0.3% | 2,800 |
| 2024/10/07 | 1,175 | 1,193 | 1,175 | 1,175 | +10 | +0.9% | 6,000 |
| 2024/10/04 | 1,163 | 1,173 | 1,160 | 1,165 | +11 | +1% | 2,000 |
| 2024/10/03 | 1,163 | 1,165 | 1,146 | 1,154 | -4 | -0.3% | 1,800 |
| 2024/10/02 | 1,175 | 1,175 | 1,150 | 1,158 | -17 | -1.4% | 5,700 |
| 2024/10/01 | 1,158 | 1,181 | 1,156 | 1,175 | +23 | +2% | 4,500 |
| 2024/09/30 | 1,139 | 1,152 | 1,125 | 1,152 | -1 | -0.1% | 2,200 |
| 2024/09/27 | 1,141 | 1,159 | 1,132 | 1,153 | +16 | +1.4% | 1,100 |
| 2024/09/26 | 1,131 | 1,148 | 1,131 | 1,137 | +6 | +0.5% | 1,400 |
| 2024/09/25 | 1,133 | 1,141 | 1,131 | 1,131 | -5 | -0.4% | 600 |
| 2024/09/24 | 1,159 | 1,160 | 1,136 | 1,136 | -20 | -1.7% | 2,600 |
| 2024/09/20 | 1,123 | 1,158 | 1,123 | 1,156 | +34 | +3% | 3,800 |
| 2024/09/19 | 1,141 | 1,141 | 1,121 | 1,122 | +11 | +1% | 1,900 |
| 2024/09/18 | 1,131 | 1,131 | 1,111 | 1,111 | -10 | -0.9% | 1,400 |
| 2024/09/17 | 1,125 | 1,134 | 1,121 | 1,121 | -16 | -1.4% | 1,700 |
| 2024/09/13 | 1,122 | 1,138 | 1,121 | 1,137 | -6 | -0.5% | 2,100 |
| 2024/09/12 | 1,124 | 1,143 | 1,116 | 1,143 | +19 | +1.7% | 900 |
| 2024/09/11 | 1,124 | 1,134 | 1,121 | 1,124 | +2 | +0.2% | 1,800 |
| 2024/09/10 | 1,120 | 1,122 | 1,120 | 1,122 | +2 | +0.2% | 700 |
1～
50
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 120,000円 | +6.8% | -13.8% | 2.67% | 9.20倍 | 0.78倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| ＶＩＳ | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
| クリングル | 84,500円 | +240.0% | - | 0.00% | - | 2.75倍 |
|
細胞の増殖、保護、修復などの機能があるＨＧＦタンパク質を用いて、難治性疾患治療薬を開発 |
| キッズバイオ | 12,100円 | - | - | 0.00% | - | 6.37倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
| ブライトパス | 5,600円 | - | - | 0.00% | - | 3.94倍 |
|
久留米大学発創薬ベンチャー。がん向け遺伝子導入ｉＰＳ由来細胞医薬や抗体医薬開発に注力 |
市場注目の銘柄
チャート関連のコラム
